UK markets close in 8 hours 3 minutes

MorphoSys AG (MOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.51+0.10 (+0.57%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.66B
Enterprise value 2.61B
Trailing P/E N/A
Forward P/E 322.58
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.41
Price/book (mrq)50.26
Enterprise value/revenue 10.97
Enterprise value/EBITDA -37.05

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3214.93%
S&P500 52-week change 323.57%
52-week high 318.31
52-week low 34.18
50-day moving average 317.93
200-day moving average 310.94

Share statistics

Avg vol (3-month) 31.85M
Avg vol (10-day) 3826.47k
Shares outstanding 5150.87M
Implied shares outstanding 6150.87M
Float 828.81M
% held by insiders 10.00%
% held by institutions 115.88%
Shares short (15 Apr 2024) 41.53M
Short ratio (15 Apr 2024) 44.54
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 41.02%
Shares short (prior month 15 Mar 2024) 42.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -190.61%
Operating margin (ttm)-960.14%

Management effectiveness

Return on assets (ttm)-13.84%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)241.47M
Revenue per share (ttm)1.72
Quarterly revenue growth (yoy)-55.80%
Gross profit (ttm)N/A
EBITDA -444.87M
Net income avi to common (ttm)-468.57M
Diluted EPS (ttm)-1.48
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)131.26M
Total cash per share (mrq)3.49
Total debt (mrq)1.73B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.38
Book value per share (mrq)-6.96

Cash flow statement

Operating cash flow (ttm)-298.22M
Levered free cash flow (ttm)-533.54M